TCF7 and endometrial carcinoma: E2F7(transcription factor 7), targeted by MIR424, miR-3666 and miR-26a, is highly expressed in multiple tumors [30,31] such as endometrial carcinoma, breast cancer, colorectal cancer and glioma, indicating that E2F7 might constitute a potential therapeutic target.